STAT+: Pharmalittle: Drugmaker raises price of old chemo med 10-fold amid shortages; Alnylam cites drug-price law in halting trial
And so, another working week will soon draw to a close. Not a moment too…
Author: STAT
Opinion: How motivational interviewing can improve health workforce well-being
The National Academy of Medicine launched its National Plan for Health Workforce Well-Being in early…
STAT+: How experts think we can put health data back ‘in the hands of the patient’
Two decades ago, the Bush administration threw a wrench in health data privacy, making it…
Opinion: STAT+: The need for regulatory grade evidence: Are you in the stadium or the sandbox?
As real-world data (RWD) and real-world evidence (RWE) continue to share the limelight in pharmacoepidemiologic…
STAT+: Death of patient in closely watched Alzheimer’s trial raises concern about risk for some groups
The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical…
STAT+: Drugmaker raises the price of an old chemo medicine tenfold amid persistent shortages
Amid sporadic shortages of a drug that is essential in preparing patients for lifesaving, cancer-fighting…
Listen: Anti-science at the polls, a biotech odd couple, & the stakes of the midterms
Can Covid denialism get you elected? How is the music business like biotech investing? And…
STAT+: A new suite of RNA-sensing tools could help scientists target cancerous cells, and much more
Sure, you’ve heard of CRISPR. But it’s 2022. The acronym you need to know now…
STAT+: Pharmalittle: Italy probes Pfizer over profit transfers; FDA postpones meeting for OTC birth control pill
Rise and shine, another busy day is on the way. However, this is also shaping…
Montana may be moving away from its innovative plan for setting hospital prices for public workers
Montana is signaling it might step away from an innovative way of setting the prices…
Opinion: Allocate opioid settlement dollars to real addiction-ending solutions
The crisis of opioid overdose deaths that sparked the multitude of lawsuits leading to a…
STAT+: Republican ideas to reform Medicare could rile health care industry
WASHINGTON — Democrats are suddenly blasting Republicans on the campaign trail over a surprising new…
Opinion: Kids with cancer deserve more than a cure
As an oncologist and a leader at a national cancer organization, I’ve watched countless families…
‘If I were a hospital, I’d be reading the tea leaves’: Pressures grow on the health care industry to reduce its climate pollution
Flooding, heat waves, wildfires, and other climate-driven weather extremes in recent years have catapulted hospitals…
For experts on stroke, Fetterman-Oz debate is a teachable moment
At a Senate debate Tuesday, the Pennsylvania Democrat John Fetterman, who is recovering from a…
STAT+: Pharmalittle: White House pharma help in plan to combat hepatitis C; J&J blood cancer drug will cost $39,500 a month
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
Virtual Event: Can We Share Health Data and Not Be Evil?
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
Test – STAT Madness Application
Apply for STAT Madness! Submit your application to be considered for the 2023 STAT Madness,…
Biotech’s newest odd couple: A pharma insider and a music maven launch a health care VC
D.A. Wallach’s first meeting with his business partner could have been the setting of a…
Opinion: After 30 years of 340B, it’s time for data and an honest conversation
The 340B Drug Discount Program turns 30 on Nov. 4. This once-obscure drug access program…
Opinion: Listen: Home health care is facing devastating ‘clawbacks’
Terry Wilcox’s grandmother lived in an isolated house at the top of a hill overlooking…
STAT+: Q&A: A health justice lawyer and new MacArthur ‘genius’ on pharma’s patent games
Priti Krishtel has had it with the patent tricks up pharma’s sleeves. The co-executive director…
When it comes to addiction, Americans’ word choices are part of the problem
Who gets better medical care in the United States: “addicts,” or “people with substance use…
STAT+: Pacific Biosciences, known for niche DNA sequencing, looks to rival Illumina with new product launch
Pacific Biosciences, a Menlo Park, Calif., firm best known for its niche approach to DNA…
STAT+: Merck fined $39 million by Spain’s antitrust regulator for ‘serious’ violation
The antitrust regulator in Spain has fined Merck approximately $39 million for preventing a competitor…
STAT+: Normunity launches with $65 million to unleash the immune system on tumors
Our best weapon against cancer may already live inside us — it just needs a…
STAT+: Pharmalittle: Online prescribing prompts scrutiny and concern; FDA is pushed to approve OTC birth control pills
Top of the morning to you. Gray skies are hovering once again over the Pharmalot…
Opinion: International concussion guidelines must protect all athletes’ brains, not just professionals’
Imagine that you are the parent of an 11-year-old soccer player who dreams of competing…
Got questions about the timing of flu and Covid vaccines? Here’s what experts say
Over the past few weeks, cases of flu have begun to creep up across the…
Opinion: Covid-19 is an inverse equity story, not a racial equity success story
As MacArthur Foundation fellow Jennifer Richeson noted in The Atlantic in 2020, Americans love to…
On the campaign trail, Republicans ramp up anti-science, anti-Covid, often anti-Fauci messaging
WASHINGTON — Even as the pandemic fades from our daily lives, it is at the…
STAT+: Pharma companies are investing in online prescribing. Who’s keeping watch?
Over the course of the pandemic, online prescribing has been embraced as a powerful tool…
Opinion: Better access to PET scans can help reduce racial inequities in Alzheimer’s disease
While many Americans are familiar with the devastating impact of Alzheimer’s disease, few understand the…
STAT+: Pharmalittle: Merck suddenly finds Ebola vaccine doses in its freezers; drugs studied to combat women’s midlife mood swings
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Keeping families out of ICUs no longer makes sense as the pandemic eases
On, December 9, 2020, my mom, brother, and I waited in a cold, wintery drizzle…
Women and men are different, cardiovascular edition
It’s quite the task to photograph someone’s heart while they’re exercising. They have to lie…
STAT+: Epic’s overhaul of a flawed algorithm shows why AI oversight is a life-or-death issue
Epic, the nation’s dominant seller of electronic health records, was bracing for a catastrophe. It…
Opinion: Medical professionals: Make your plan to vote now. Then vote!
The U.S. is less than three weeks from the 2022 midterm elections, which will decide…
STAT+: This summer’s Covid surge was bad for hospital profits
This summer’s Covid-19 surge put a sizable dent in hospital finances, with two large investor-owned…
STAT+: Inside Michelle McMurry-Heath’s departure from BIO: Firings, internal clashes, and a pivotal job review
WASHINGTON — Only two years ago, Michelle McMurry-Heath was named chief executive of BIO, the…
STAT+: Pharmalittle: Pfizer plans to quadruple price of its Covid-19 vaccine; pharma pushed to tie exec compensation to access to meds
And so, another working week will soon draw to a close. Not a moment too…
FDA’s vaccines chief sees possibility of more Covid boosters — sooner than he’d like
Peter Marks, who leads the Food and Drug Administration’s vaccines operation, is still losing sleep…
Opinion: Research funding is broken. Using a lottery approach could fix it
Thirty years ago, Katalin Karikó had what was then an outlandish idea: use messenger RNA…
Opinion: Support family caregivers to improve and diversify clinical trials
During the Covid-19 pandemic, America’s 53 million family caregivers gained some long overdue recognition for…
Medicare is going to cap patients’ spending on drugs. But there’s no such limit for hospital or doctor bills
By 2025, people on Medicare who take expensive medications will feel significant financial relief: They…
STAT+: Dozens of institutional investors urge drugmakers to link executive compensation to access to medicines
Three dozen institutional investors are urging the boards at several of the world’s largest pharmaceutical…
.jpg)
BU’s Covid tinkering, FDA on trial, & why it’s hard to take drugs off the market
What happens when approved drugs turn out not to work? Is it OK to make…
STAT+: Novartis agrees to license a best-selling cancer drug to dozens of low- and middle-income countries
Amid a push to widen access to medicines to poor countries, Novartis has reached an…
U.S. surgeon general says workplaces are taking a toll on Americans’ mental and physical health
Your job can be hazardous to your health, according to a new report from the…
STAT+: How one pharma insider sees the drug pricing reform law: the impact will ‘vary by product and by company’
After years of stops and starts, a law was finally passed in Congress this summer…